骨桥BCI 602植入在双侧小耳闭锁综合征和非综合征患者中的应用

IF 1.2 4区医学 Q3 OTORHINOLARYNGOLOGY

International journal of pediatric otorhinolaryngology Pub Date : 2025-04-29 DOI:10.1016/j.ijporl.2025.112370

Tai-Yu Chen , Kuang-Hsu Lien , Kuan-Ting Yeh , Junior Chun-Yu Tu , Valerie Wai-Yee Ho , Kai-Chieh Chan

{"title":"骨桥BCI 602植入在双侧小耳闭锁综合征和非综合征患者中的应用","authors":"Tai-Yu Chen , Kuang-Hsu Lien , Kuan-Ting Yeh , Junior Chun-Yu Tu , Valerie Wai-Yee Ho , Kai-Chieh Chan","doi":"10.1016/j.ijporl.2025.112370","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the safety and efficacy of Bonebridge bone conduction implant (BCI) 602 implantation in syndromic and non-syndromic patients with bilateral microtia and aural atresia (AA).</div></div><div><h3>Methods</h3><div>This retrospective study included 15 patients (3 syndromic, 12 non-syndromic) with bilateral microtia and AA who underwent BCI 602 implantation at a tertiary medical center between January 2022 and June 2024. Intraoperative and postoperative complications were recorded, with a minimum follow-up of six months. Audiological outcomes, including functional hearing gain (FHG), speech reception threshold (SRT), and word recognition score (WRS), were analyzed.</div></div><div><h3>Results</h3><div>No intraoperative complications occurred in any cases. One minor postoperative complication (6.7 %) was reported in a non-syndromic patient during follow-up. The mean unaided and aided sound field threshold pure tone averages were 60.3 ± 8.7 dB HL and 23.8 ± 3.9 dB HL, respectively, yielding an FHG of 36.6 ± 9.3 dB HL (<em>p</em> < 0.05). SRT improved from 57.0 ± 5.9 dB HL to 27.0 ± 6.5 dB HL in quiet and from 0.3 ± 8.5 dB SNR to −10.7 ± 4.2 dB SNR in noise. WRS increased from 45.1 ± 20.7 % to 89.9 ± 5.6 % in quiet and from 40.9 ± 20.9 % to 80.9 ± 13.8 % in noise (<em>p</em> < 0.05). Improvements in FHG, SRT, and WRS were comparable between syndromic and non-syndromic groups (<em>p</em> > 0.05).</div></div><div><h3>Conclusions</h3><div>The Bonebridge BCI 602 is a safe and effective option for hearing restoration in both syndromic and non-syndromic patients with bilateral microtia and AA. Its compact design enhances surgical safety and minimizes risks to critical structures, particularly in syndromic patients with complex temporal bone anatomy.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"193 ","pages":"Article 112370"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bonebridge BCI 602 implantation in syndromic and non-syndromic patients with bilateral microtia and aural atresia\",\"authors\":\"Tai-Yu Chen , Kuang-Hsu Lien , Kuan-Ting Yeh , Junior Chun-Yu Tu , Valerie Wai-Yee Ho , Kai-Chieh Chan\",\"doi\":\"10.1016/j.ijporl.2025.112370\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To evaluate the safety and efficacy of Bonebridge bone conduction implant (BCI) 602 implantation in syndromic and non-syndromic patients with bilateral microtia and aural atresia (AA).</div></div><div><h3>Methods</h3><div>This retrospective study included 15 patients (3 syndromic, 12 non-syndromic) with bilateral microtia and AA who underwent BCI 602 implantation at a tertiary medical center between January 2022 and June 2024. Intraoperative and postoperative complications were recorded, with a minimum follow-up of six months. Audiological outcomes, including functional hearing gain (FHG), speech reception threshold (SRT), and word recognition score (WRS), were analyzed.</div></div><div><h3>Results</h3><div>No intraoperative complications occurred in any cases. One minor postoperative complication (6.7 %) was reported in a non-syndromic patient during follow-up. The mean unaided and aided sound field threshold pure tone averages were 60.3 ± 8.7 dB HL and 23.8 ± 3.9 dB HL, respectively, yielding an FHG of 36.6 ± 9.3 dB HL (<em>p</em> < 0.05). SRT improved from 57.0 ± 5.9 dB HL to 27.0 ± 6.5 dB HL in quiet and from 0.3 ± 8.5 dB SNR to −10.7 ± 4.2 dB SNR in noise. WRS increased from 45.1 ± 20.7 % to 89.9 ± 5.6 % in quiet and from 40.9 ± 20.9 % to 80.9 ± 13.8 % in noise (<em>p</em> < 0.05). Improvements in FHG, SRT, and WRS were comparable between syndromic and non-syndromic groups (<em>p</em> > 0.05).</div></div><div><h3>Conclusions</h3><div>The Bonebridge BCI 602 is a safe and effective option for hearing restoration in both syndromic and non-syndromic patients with bilateral microtia and AA. Its compact design enhances surgical safety and minimizes risks to critical structures, particularly in syndromic patients with complex temporal bone anatomy.</div></div>\",\"PeriodicalId\":14388,\"journal\":{\"name\":\"International journal of pediatric otorhinolaryngology\",\"volume\":\"193 \",\"pages\":\"Article 112370\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of pediatric otorhinolaryngology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165587625001570\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pediatric otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165587625001570","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的评价骨桥骨传导植入（BCI） 602治疗双侧小耳闭锁（AA）综合征型和非综合征型患者的安全性和有效性。方法回顾性研究于2022年1月至2024年6月在某三级医疗中心行BCI 602植入术的双侧小脑和AA患者15例（3例综合征型，12例非综合征型）。记录术中和术后并发症，至少随访6个月。分析听力学指标，包括功能性听力增益（FHG）、语音接收阈值（SRT）和单词识别评分（WRS）。结果所有病例均无术中并发症发生。在随访期间，无综合征患者报告了一例轻微的术后并发症（6.7%）。独立声场和辅助声场阈值纯音平均值分别为60.3±8.7 dB HL和23.8±3.9 dB HL， FHG为36.6±9.3 dB HL (p <；0.05)。安静时SRT从57.0±5.9 dB HL提高到27.0±6.5 dB HL，噪声时SNR从0.3±8.5 dB SNR提高到−10.7±4.2 dB SNR。安静环境下WRS从45.1%±20.7%增加到89.9%±5.6%，噪声环境下WRS从40.9±20.9%增加到80.9±13.8% (p <；0.05)。FHG、SRT和WRS的改善在综合征组和非综合征组之间具有可比性(p >；0.05)。结论Bonebridge BCI 602是一种安全有效的听力修复方法，适用于双侧小耳畸形和双侧失聪的综合征型和非综合征型患者。其紧凑的设计提高了手术安全性，并最大限度地降低了对关键结构的风险，特别是在颞骨解剖复杂的综合征患者中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Bonebridge BCI 602 implantation in syndromic and non-syndromic patients with bilateral microtia and aural atresia

Objective

To evaluate the safety and efficacy of Bonebridge bone conduction implant (BCI) 602 implantation in syndromic and non-syndromic patients with bilateral microtia and aural atresia (AA).

Methods

This retrospective study included 15 patients (3 syndromic, 12 non-syndromic) with bilateral microtia and AA who underwent BCI 602 implantation at a tertiary medical center between January 2022 and June 2024. Intraoperative and postoperative complications were recorded, with a minimum follow-up of six months. Audiological outcomes, including functional hearing gain (FHG), speech reception threshold (SRT), and word recognition score (WRS), were analyzed.

Results

No intraoperative complications occurred in any cases. One minor postoperative complication (6.7 %) was reported in a non-syndromic patient during follow-up. The mean unaided and aided sound field threshold pure tone averages were 60.3 ± 8.7 dB HL and 23.8 ± 3.9 dB HL, respectively, yielding an FHG of 36.6 ± 9.3 dB HL (p < 0.05). SRT improved from 57.0 ± 5.9 dB HL to 27.0 ± 6.5 dB HL in quiet and from 0.3 ± 8.5 dB SNR to −10.7 ± 4.2 dB SNR in noise. WRS increased from 45.1 ± 20.7 % to 89.9 ± 5.6 % in quiet and from 40.9 ± 20.9 % to 80.9 ± 13.8 % in noise (p < 0.05). Improvements in FHG, SRT, and WRS were comparable between syndromic and non-syndromic groups (p > 0.05).

Conclusions

The Bonebridge BCI 602 is a safe and effective option for hearing restoration in both syndromic and non-syndromic patients with bilateral microtia and AA. Its compact design enhances surgical safety and minimizes risks to critical structures, particularly in syndromic patients with complex temporal bone anatomy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International journal of pediatric otorhinolaryngology 医学-耳鼻喉科学

CiteScore

3.20

自引率

6.70%

发文量

276

审稿时长

62 days

期刊介绍： The purpose of the International Journal of Pediatric Otorhinolaryngology is to concentrate and disseminate information concerning prevention, cure and care of otorhinolaryngological disorders in infants and children due to developmental, degenerative, infectious, neoplastic, traumatic, social, psychiatric and economic causes. The Journal provides a medium for clinical and basic contributions in all of the areas of pediatric otorhinolaryngology. This includes medical and surgical otology, bronchoesophagology, laryngology, rhinology, diseases of the head and neck, and disorders of communication, including voice, speech and language disorders.